中孚药业

Beijing Zhongfu Pharmaceutical is a comprehensive pharmaceutical enterprise based in Beijing, China, specializing in the research, production, and distribution of chemical drugs and traditional Chinese medicines. The company's product portfolio is notably strong in oncology, particularly with its production of fluorouracil-based treatments, as well as cardiovascular and anti-infective therapies. Operating with modern GMP-certified facilities, Zhongfu provides a variety of dosage forms including injections, tablets, and capsules to the healthcare market. The firm emphasizes the modernization of traditional Chinese medicine alongside the development of high-quality generic pharmaceuticals. Its manufacturing capabilities support large-scale production of both active pharmaceutical ingredients and finished dosage forms. Zhongfu maintains a significant presence in the domestic Chinese hospital market through a robust distribution network.